Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Co-development of a new medicinal product

Reference number
Coordinator ZuLa Diagnostics AB
Funding from Vinnova SEK 25 000
Project duration September 2018 - December 2018
Status Completed

Purpose and goal

We have had several B2B meetings in Beijing, Nanjing and Shanghai. This has given us some good contacts for further discussions and potential collaboration.

Expected results and effects

We are looking forward to have visitors from Nanjing coming to Stockholm to continue discussions before the end of the year.

Planned approach and implementation

Keep the discussions going on-line and prepare for the visit to Stockholm.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 24 October 2018

Reference number 2018-03212

Page statistics